ORN Spring 2024 - Opioid Use Disorder in Youth-2024-04-10 - Recording - ORN Spring 2024 - OUD in Youth

2024-04-10 - Recording - ORN Spring 2024 - OUD in Youth - Welsh, MD

Video Transcription

Video Summary

In today's webinar, Dr. Justine Welsh discussed opioid use disorder in youth. She highlighted the underutilization of medication for opioid use disorder (MOUD) in adolescents, despite FDA approval for buprenorphine in ages 16 and older. Dr. Welsh emphasized the importance of combining behavioral therapies with medication to improve treatment retention in youth. She also shared insights on the challenges faced in transitioning youth to extended release products like Sublocate and Brixadi. Additionally, Dr. Welsh addressed concerns about the increasing recreational use of Kratom products and the potential impact on youth. Concerns were raised about the abrupt cessation of MOUD in residential treatment settings, leading to withdrawal symptoms and heightened overdose risk. Dr. Welsh suggested a need for improved understanding and support for youth with opioid use disorder to enhance treatment retention and reduce the stigma associated with medication.

Keywords

webinar

Dr. Justine Welsh

opioid use disorder

medication for opioid use disorder

MOUD

adolescents

buprenorphine

behavioral therapies

extended release products

Kratom products